期刊文献+

生物羊膜与MMC在青光眼术中的应用比较 被引量:1

Comparison of Biological Amnion and MMC in Glaucoma Surgery
下载PDF
导出
摘要 目的 探讨生物羊膜与丝裂霉素C(MMC)在青光眼手术中的应用效果。方法 选取2008年1月-2009年11月于我院进行治疗的50例(74眼)青光眼患者为研究对象,将其随机分为生物羊膜组(A组)26例(38眼)和MMC组(B组)24例(36眼),对两组患者的并发症发生率、视力水平、术后1周及1、6个月的眼压及患者满意率进行统计及比较。结果 经研究比较发现,A组的并发症发生率低于B组,视力改变小于B组,患者满意率高于B组,同时术后1周及1个月的眼压A组低于B组(P均〈0.05),而术后6个月两组眼压比较,无显著性差异(P〉0.05)。结论 在青光眼手术中运用生物羊膜的效果较佳,综合优势较大,值得临床推广应用。 Objective To investigate the effects of biological amnion and MMC in the glaucoma surgery. Methods Fifty cases(60 eyes)of glaucoma in our hospital from Jan. 2008 to Nov. 2009 were selected as research objects, and they were randomly divided into biological amnion group(group A)26 cases(38 eyes)and MMC group(group B)24 cases(36 eyes). Then the incidence of complication, vision,intraocular pressure at one week,one month and six months after the operation and the satisfaction rate were analyzed and compared. Results The incidence of complication of Group A was lower than that of Group B, the vision change of Group A was less than that of Group B,the satisfaction rate of Group A was higher than that of Group B,the intraocular pressure of Group A at one week and one month after the operation was lower than that of group B (P〈0.05) and the intraocular pressure of the two groups at six months after the operation showed no difference(P〉0.05). Conclusion The effect of biological amnion in glaucoma surgery is better,with a comprehensive advantage,worthy of further popularization and application.
作者 冯小成 孙康
出处 《中国现代医生》 2010年第16期48-49,共2页 China Modern Doctor
关键词 生物羊膜 MMC 青光眼 Biological amnion MMC Glaucoma
  • 相关文献

参考文献3

二级参考文献20

  • 1孙兴怀.难治性青光眼的治疗[J].国外医学(眼科学分册),1995,19(1):26-31. 被引量:201
  • 2夏晓波.丝裂霉素C在青光眼滤过性手术中的应用[J].国外医学(眼科学分册),1995,19(1):18-22. 被引量:87
  • 3吴玲玲,尹金福.丝裂霉素C在难治性青光眼滤过术中的应用[J].中华眼科杂志,1996,32(1):32-34. 被引量:44
  • 4姜发纲,魏厚仁,吕源淑.5-氟尿嘧啶对体外培养牛眼小梁细胞的毒性研究[J].中华眼科杂志,1996,32(6):432-434. 被引量:4
  • 5Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells[J]. Nature 1985;316(6030) :701-705.
  • 6Merrilees M, Beaumont B, Scott L, Hermanutz V, Fenuessy P. Effect of TGF-beta ( 1 ) antisense S-oligonucleotide on synthesis and accumulation of matrix proteoglyeans in balloon catheter-injured neointima of rabbit carotid arteries[ J]. J Vasc Res 2000 ;37
  • 7Roy CL, Leduque P, Li JY, Seaz JM, Langlois D. Antisense oligonucleotide targeting the transforming growth factor β1 increases expression of specific genes and functions of Leydig cells[ J].Eur J Biochem 1998; 257 (2): 506-514.
  • 8Hatzfeld J, Li ML, Brown EL, Sookdeo H, Levesque JP, O′Toole T, et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 of Rb oligonucleotides [ J ]. JExp Med 1991; 174(4) :925-929.
  • 9Han DC,Hoffman BB,Hong SW,Guo J,Ziyadeh FN. Therapy with antisense TGF-beta 1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice [ J].Am J Physiol Renal Physiol 2000;278(4) :F628-634.
  • 10Li J, Tripathi BJ, Tripathi RC. Modulation of pre-mRNA splicing and protein production of fibronectin by TGFbeta 2 in porcine trabecular cells[ J]. Invest Ophthalmol Vis Sci 2000:41(11) :3437-3443.

共引文献25

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部